Buchang Pharmaceutical announced that the controlling shareholder of the company, Bu Chang held 490,957,202 shares, accounting for 46.56%, and pledged a total of 108,530,000 shares, accounting for 22.11% of the shares and 10.29% of the total share capital. This time, 7,600,000 additional shares were pledged, of which 3,600,000 shares were pledged to the Jinan branch of China CITIC Bank Co., Ltd., and 4,000,000 shares were pledged to CITIC Financial Leasing Co., Ltd., with an average pledge starting date of 2025.12.29, and the latter's expiration date is 2028.12.30. The controlling shareholders and co-actors held a total of 598,200,660 shares, accounting for 56.72%, and pledged 108,530,000 shares, accounting for 18.14% of the shares and 10.29% of the total share capital.

Buchang Pharmaceutical announced that the controlling shareholder of the company, Bu Chang held 490,957,202 shares, accounting for 46.56%, and pledged a total of 108,530,000 shares, accounting for 22.11% of the shares and 10.29% of the total share capital. This time, 7,600,000 additional shares were pledged, of which 3,600,000 shares were pledged to the Jinan branch of China CITIC Bank Co., Ltd., and 4,000,000 shares were pledged to CITIC Financial Leasing Co., Ltd., with an average pledge starting date of 2025.12.29, and the latter's expiration date is 2028.12.30. The controlling shareholders and co-actors held a total of 598,200,660 shares, accounting for 56.72%, and pledged 108,530,000 shares, accounting for 18.14% of the shares and 10.29% of the total share capital.